Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Melbourne researchers develop genetic test to predict risk of autism spectrum disorder

A team of Australian researchers, led by University of Melbourne has developed a genetic test that is able to predict the risk of developing Autism Spectrum Disorder, ASD.

13 Sep 2012

Roundup: Mich. Gov. proposes making BCBS a tax-paying insurer; Merger creates one of largest hospitals in Conn.; W. Va. chiropractor board scrutinized

Blue Cross Blue Shield of Michigan would no longer be exempt from about $100 million a year in state and local taxes but would be subject to more streamlined and speedier rate reviews and approvals under legislation proposed today by Gov. Rick Snyder. The nonprofit health insurer would also pay $1.5 billion over 18 years into a separate nonprofit aimed at tackling issues such as obesity and infant mortality to improve the health of all Michigan residents, Snyder said at a news conference.

13 Sep 2012

Breakthrough for dengue vaccine development

A live-attenuated vaccine against the four strains of dengue virus known as CYD-TDV has demonstrated promising efficacy in a phase IIb trial.

12 Sep 2012

Combination chemotherapy confirmed viable for penile cancer

A combination of cisplatin and 5-fluorouracil is an effective and well-tolerated regimen for patients with squamous cell carcinoma of the penis, show study findings.

12 Sep 2012

Early CATCH improves thrombocytopenia outcomes

One in five patients using heparin to protect against venous thromboembolism develops thrombocytopenia, reveal results from the CATCH Registry.

12 Sep 2012

UB researchers receive NFL grant for sports-related medical research on concussion

After sustaining a concussion, when can an athlete safely return to play? That's the primary question for professional and amateur athletes alike. Now, University at Buffalo sports medicine researchers have been awarded $100,000 from NFL Charities to develop the most objective, scientific method of determining when an athlete who has had a concussion can safely return to play.

12 Sep 2012

Genetic test predicts risk for Autism

A team of Australian researchers, led by University of Melbourne has developed a genetic test that is able to predict the risk of developing Autism Spectrum Disorder, ASD.

11 Sep 2012

Specific white matter connectivity reduced in anxiety patients

Patients with generalized anxiety disorder have reduced functional connectivity between areas of the brain associated with fight-or-flight response and emotion regulation, researchers report.

11 Sep 2012

Warning over sirolimus in HCV-positive liver transplantation

Sirolimus, whether given at the time of liver transplantation or after, is associated with poorer outcomes in patients with hepatitis C virus infection compared with those who do not take the immunosuppressant, shows a US study.

10 Sep 2012

'No malignancy risk' with biologic response modifiers

Rheumatoid arthritis patients treated with biologic response modifiers for at least 6 months do not have a greater risk for malignancy than those given other disease-modifying drugs or placebo, conclude US and Spanish researchers.

10 Sep 2012

Physician empathy has positive impact on patient outcomes

Patients of doctors who are more empathic have better outcomes and fewer complications, concludes a large, empirical study by a team of Thomas Jefferson University and Italian researchers who evaluated relationships between physician empathy and clinical outcomes among 20,961 diabetic patients and 242 physicians in Italy.

10 Sep 2012

Phase III data for Suvorexant, an investigational insomnia medicine, announced

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. The new data are from one of the longest, continuously-dosed, placebo-controlled trials of a sleep medication ever conducted.

10 Sep 2012

TauRx initiates LMTX Phase 3 trial in Pick's Disease

TauRx Therapeutics today announced the initiation of a global Phase 3 clinical trial in a type of Frontotemporal Dementia (FTD) also known as Pick's Disease. The announcement, which immediately follows The 8th International Conference on Frontotemporal Dementias, held 5-7 September in Manchester, England, underscores the need for new treatments for this form of dementia that is similar to Alzheimer's Disease, except that it tends to damage different areas of the brain and affects people as early as 40 years old.

10 Sep 2012

Employment may reduce risk of mental health problems among Somalis in London

Somali immigrants to the UK and USA appear to integrate better and have fewer mental health problems if they are allowed to work and they receive practical support during the first few years of their time in the new country, according to a study led by researchers at Queen Mary, University of London (UK) and published in BioMed Central Public Health.

10 Sep 2012

Bullying prevention experts available for comment

Bullying was once considered a childhood rite of passage. Today, however, bullying is recognized as a serious problem. Up to half of all children are bullied at some point during their school years, according to the American Academy of Child and Adolescent Psychiatry. And thanks to tech-savvy kids, cyberbullying and other forms of electronic harassment are now commonplace.

7 Sep 2012

Antipsychotic-induced obsessive compulsive symptoms assessed

Results from a Korean study show that the symptom structure of second-generation-antipsychotic-induced obsessive compulsive symptoms is similar to that seen in patients with “pure” obsessive compulsive disorder.

7 Sep 2012

Centralized network may reduce inappropriate filled prescriptions

Implementing a centralized network that links province-wide pharmacy and hospital data could reduce the number of inappropriate filled prescriptions, show Canadian study results.

7 Sep 2012

BCAA supplementation may treat autism and/or epilepsy

An international team of researchers, led by scientists at the University of California, San Diego and Yale University schools of medicine, have identified a form of autism with epilepsy that may potentially be treatable with a common nutritional supplement.

7 Sep 2012

Constipation drug may bring US patients relief

The US Food and Drug Administration has approved linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.

6 Sep 2012

Night eating syndrome increased in schizophrenia patients

The prevalence of night eating syndrome is significantly increased among patients with schizophrenia or schizoaffective disorder who are obese, results from a US study suggest.

6 Sep 2012